All filters
Slidesets
Optimizing Clinical Utility of Integrase Inhibitors- Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Identification of rapid and emerging transmission clusters from genetic network- Tsz Ho Kwa
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Vaccine induced susceptibility vs protection- Roger Legrand
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Phylogenetic, epidemiological and virological insights on the rise of large cluster outbreaks fueling the HIV-1 epidemic among Men having sex with Men within Quebec-Bluma Brenner
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Making PrEP a succes- Annemarie Wensing, MD, PhD
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Behaviour perspective- Ian McGowan, MB, ChB, DPhil, MD, FRCP
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
HIV-1 Vif adaptation to host immune pressure impact of cytidine deaminases and host HLA- Nicole Reddy
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Trafficking of HIV out of the mucosa- Claudia Cicala, PhD
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Introduction: Using transmission networks for targeted interventions- Charles Boucher, MD, PhD
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Transmitted drug-resistance in newly diagnosed HIV drug-naïve individuals in Portugal- Marta Sofia Pingarilho
Presented at:
International Workshop on HIV Transmission 2017
Slidesets
Hepatitis E in HIV- Kenneth Sherman, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
News on hepatitis delta and HIV infections- Vincent Soriano, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Management of HCV in intravenous drug users: special considerations- Rui Sarmento e Castro, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
EASL highlights 2017- Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Management of end-stage liver disease in HIV patients- Ana Morbey, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
New insights in management of HIV/HBV co-infected patients- Juan Berenguer, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
HBV cure: what is coming in 5 – 10 years?- Patrick Kennedy, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Debate case based: Do we need resistance testing in HCV therapy to guide decision making? Pro stance- Francesca Ceccherini– Silberstein, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Special considerations before / during / after DAA therapy- Kosh Agarwal, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Virologist's perspective - Charles Boucher, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Debate case based: Do we need resistance testing in HCV therapy to guide decision making? Con stance (Not available)- Mark Nelson, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Pharmacologist's perspective- David Back, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Are there any special populations in treatment of HCV left?- Douglas Dieterich, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
HCV chronic infection treatment with DAA: who are the patients that are not achieving sustained virologic response?- R. Valente
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017